ColoAlert® Revenue Increases 102% Year Over Year for the Nine Months Ended September 30, 2023ColoFuture Study Reported Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 94%.
EQS-News: Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Mainz Biomed (MYNZ) Reports Q3 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The FTC’s Amgen/Horizon Lawsuit Ends With a Whimper - We covered the FTC’s investigation into (and litigation challenging) Amgen’s $28.3 billion acquisition of rare.
BETHESDA, Md., Sept. 25, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today.